122 related articles for article (PubMed ID: 17302995)
1. Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention.
Yan JC; Ding S; Liang Y; Ma GS; Zhu J; Feng Y; Luo D
Acta Pharmacol Sin; 2007 Mar; 28(3):339-43. PubMed ID: 17302995
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of CD40-CD40 ligand system in patients with essential hypertension.
Yan JC; Ma GS; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2005 May; 355(1-2):191-6. PubMed ID: 15820495
[TBL] [Abstract][Full Text] [Related]
3. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218
[TBL] [Abstract][Full Text] [Related]
4. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction.
Ohashi Y; Kawashima S; Mori T; Terashima M; Ichikawa S; Ejiri J; Awano K
Int J Cardiol; 2006 Sep; 112(1):52-8. PubMed ID: 16376442
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
8. Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure.
Yan JC; Liu PJ; Du RZ; Liang Y; Ma GS; Zhu J; Luo D
Clin Chim Acta; 2008 Jun; 392(1-2):17-20. PubMed ID: 18339317
[TBL] [Abstract][Full Text] [Related]
9. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine modulates the CD40/CD40L system.
Prontera C; Martelli N; Evangelista V; D'Urbano E; Manarini S; Recchiuti A; Dragani A; Passeri C; Davì G; Romano M
J Am Coll Cardiol; 2007 Jun; 49(22):2182-90. PubMed ID: 17543638
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.
Harding SA; Sarma J; Josephs DH; Cruden NL; Din JN; Twomey PJ; Fox KA; Newby DE
Circulation; 2004 Apr; 109(16):1926-9. PubMed ID: 15078798
[TBL] [Abstract][Full Text] [Related]
12. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.
Hammwöhner M; Ittenson A; Dierkes J; Bukowska A; Klein HU; Lendeckel U; Goette A
Exp Biol Med (Maywood); 2007 Apr; 232(4):581-9. PubMed ID: 17392495
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
[TBL] [Abstract][Full Text] [Related]
14. The clinical implications of increased coexpression of CD40-CD40 ligand system and C-reactive protein in patients after percutaneous coronary intervention.
Yan JC; Ma GS; Zhu J; Feng Y; Luo D; Wu ZG; KingG XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2006 Dec; 374(1-2):140-1. PubMed ID: 16820144
[No Abstract] [Full Text] [Related]
15. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
16. Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft.
Osmancik PP; Bednar F; Pavkova L; Tousek P; Stros P; Jirasek K
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):807-12. PubMed ID: 19002048
[TBL] [Abstract][Full Text] [Related]
17. Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes.
Dongming L; Zuxun L; Liangjie X; Biao W; Ping Y
Clin Chim Acta; 2010 Mar; 411(5-6):406-10. PubMed ID: 20026323
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of increased expression of CD40L in patients with acute coronary syndromes.
Yan J; Wu Z; Huang Z; Li L; Zhong R; Kong X
Chin Med J (Engl); 2002 Apr; 115(4):491-3. PubMed ID: 12133281
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Chung I; Choudhury A; Patel J; Lip GY
J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]